Tylenol Autism Lawsuit Guide & Settlements (2026)
Contributor
Reviewed ByAdam Ramirez, J.D.
Editor
What compensation might be available in Tylenol autism lawsuits?
Quick Answer:
Compensation amounts may vary significantly based on the severity of the autism spectrum disorder, with Level 1 cases typically resulting in tens of thousands of dollars, while Level 3 cases could potentially reach hundreds of thousands or even millions of dollars.
Summary
- The Second Circuit revived the MDL on July 13, 2026
- As of August 2026, there are 58 pending actions
- Hundreds of other plaintiffs may be able to join the MDL
Lawsuit Updates
- As of August 3, 58 lawsuits were pending.
- U.S. Health and Human Services Found an Old Tylenol Tweet Saying Products Shouldn’t Be Used During Pregnancy.
- U.S. Court of Appeals 2nd Circuit Scheduled Oral Arguments for October 6.
Free Tylenol Lawsuit Case Review!
Mentioned by
- Current Status of the Tylenol Litigation
- What Is the Tylenol Lawsuit?
- How Much Money Can I Get Through a Tylenol Autism Lawsuit?
- Predicting the Tylenol Lawsuit Payout per Person
- How Much Is the Tylenol Autism Settlement for Various Levels of Autism?
- Should I File a Tylenol Lawsuit or Join an MDL?
- Has Your Child Been Harmed by Tylenol Exposure?
Current Status of the Tylenol Litigation
In August 2026, the Judicial Panel on Multidistrict Litigation (JPML) reported that there are 58 cases pending in MDL 3043, commonly called the “Tylenol lawsuit.” There have been 722 total cases filed since it began in 2022.
However, a new development means that hundreds of previously dismissed cases may be revived, and hundreds of other people may file for the first time.
Back in August 2024, Judge Denise Cote issued a summary judgment ending federal litigation. She stated that the plaintiffs’ expert witness, Dr. Roberta Ness, wasn’t qualified to argue that Tylenol caused autism.
The following month, plaintiffs filed an appeal. They claimed that Judge Cote chose one side of the scientific debate instead of allowing a jury to hear and weigh the evidence.
On July 13, 2026, the Second Circuit ruled in favor of the plaintiffs in a unanimous decision.
It found that Judge Cote exceeded her gatekeeping role. It revived hundreds of previous lawsuits, sending them back to district court.
In some MDLs, like the Monsanto glyphosate lawsuit, courts have ruled that federal labeling laws invalidate failure-to-warn claims.
The Second Circuit explicitly allowed failure-to-warn claims in the Tylenol lawsuit. It noted that federal labeling requirements don’t prohibit manufacturers from issuing warnings about specific risks like autism.
Older Developments
On September 22, 2025, President Trump announced a press conference on autism and its alleged link to Tylenol. In light of that new development, the U.S. Court of Appeals for the Second Circuit pushed oral arguments back from October 6 to November 17.
This was also the day the Food and Drug Administration (FDA) began the process to change acetaminophen’s label to reflect the risk of autism and other neurological conditions. It noted that no causal relationship has been established and that acetaminophen is still the safest over-the-counter painkiller for pregnant women.
Over the course of the litigation, multiple new studies have come out, and their findings support the plaintiffs. One of the most notable involved a review of 46 separate studies on acetaminophen use during pregnancy. It found that most studies showed a connection between autism (as well as ADHD and other neurodevelopmental disorders) and Tylenol exposure in utero.
What Is the Tylenol Lawsuit?
Tylenol, a widely used over-the-counter (OTC) medicine, is known for its pain-relieving (analgesic) and fever-reducing (antipyretic) properties. It is often recommended for conditions such as headaches, osteoarthritis, and cold symptoms. Each week, approximately one-quarter (23%) of the U.S. population uses acetaminophen-containing medications, according to the Consumer Healthcare Products Association (CHPA).
In recent years, a handful of studies suggest that Tylenol use during pregnancy may be associated with neurological and developmental conditions, including autism spectrum disorder (ASD) and attention-deficit/hyperactivity disorder (ADHD) in children. A study released by the National Institutes of Health (NIH) in 2019 suggested that a child’s exposure to acetaminophen (the generic drug name for the brand name Tylenol) in the mother’s womb may increase the risk of developing ASD and ADHD.
The CDC’s Autism and Developmental Disabilities Monitoring (ADDM) Network found that as of 2022, about one in every 31 eight-year-old children (about 3.2%) was estimated to have autism spectrum disorder (ASD). After the findings, hundreds of Tylenol autism lawsuits have been filed against the manufacturers of Tylenol and retailers.
In a typical Tylenol lawsuit, plaintiffs (parents whose children were diagnosed with ASD and/or ADHD) claim that manufacturers did not sufficiently warn consumers of the side effects of acetaminophen during pregnancy, similar to the Gardasil lawsuits where plaintiffs allege Merck failed to warn users of long-term side effects of the Gardasil vaccine. Many plaintiffs are joining MDLs to take advantage of the power of numbers. The more people join an MDL against Tylenol manufacturers, the more attention it will draw from other people who may have suffered similar harm.
Is the Tylenol Autism Lawsuit Real?
The suggested link between the use of Tylenol and autism has given rise to hundreds of lawsuits on both the federal and state level. The lawsuits name Kenvue as the leading defendant. Johnson & Johnson turned its consumer health business into Kenvue in 2023. In these lawsuits, plaintiffs reference scientific evidence suggesting that the prolonged use of Tylenol during pregnancy increases the risk of autism and ADHD in children.
In October 2025, Texas Attorney General Ken Paxton filed a lawsuit against Kenvue and J&J for deceptive marketing. He accused J&J of creating Kenvue to offload legal liability.
How Much Money Can I Get Through a Tylenol Autism Lawsuit?
Many lawsuits against pharmaceutical companies – or, in the case of J&J, pharmaceutical conglomerates – are resolved through a settlement. Parties can reach a settlement either before a lawsuit is filed or during the pre-trial phase after the filing. However, many cases cannot be resolved through a settlement and require a trial. The amount of money you can get through a Tylenol lawsuit — either an individual lawsuit or as part of the ongoing MDL — depends on the specific details of your case and how badly you or your child was affected. Your case could potentially be worth tens or even hundreds of thousands of dollars. This could include compensation for medical bills, emotional distress, lost wages, and other damages.
Predicting the Tylenol Lawsuit Payout per Person
No Tylenol case alleging a link between a child’s autism or ADHD has settled. The manufacturers and retailers defending these lawsuits knocked out the majority of cases in the MDL fairly early in the process, so none had gone far enough to get a jury award or settlement.
Since there are no past awards to predict possible future awards, you must rely on remedies law to estimate them. When you win a lawsuit, you can pursue compensation for both economic and non-economic losses.
Economic losses represent the financial cost of your child’s condition. Medical bills, counseling, lost income, and caretaking might qualify as economic losses. Non-economic losses represent the erosion in their quality of life due to their conditions. These compensate your child for their mental anguish and inability to participate in activities.
How Much Is the Tylenol Autism Settlement for Various Levels of Autism?
The major factor that determines the payout is the seriousness of ADHD or Autism disorder and how much a pregnant woman takes acetaminophen. The seriousness and severity of these disorders, especially Autism, are measured in three distinct units: ASD level 1, ASD level 2, and ASD level 3. The first level is less severe, while the third level has greater severity of ASD.
Lawsuit settlements will likely depend on the seriousness of ASD or autism. However, because no bellwether trial has been held yet, estimating exact settlement amounts isn’t possible.
Autism Spectrum Disorder Level 1
Level 1 Autism, often referred to as "high-functioning autism," generally results in lower settlements. Children with this level can articulate well but struggle with social norms and executive functions similar to those with ADHD. However, even children at the lowest level will feel the effects of their condition for their entire lives.
Autism Spectrum Disorder Level 2
For Level 2 Autism, which involves more pronounced communication and behavioral issues, the estimated compensation is higher than that for level 1. These children face challenges in adapting to and deviating from routine activities. As a result, they may need significant treatment and assistance.
Autism Spectrum Disorder Level 3
Level 3 Autism, the most severe form, may lead to the highest possible compensation. Children at this level face extreme difficulties in both verbal and non-verbal communication and are highly restricted in their activities and interactions. These children might need to pay for residential care or full-time caretakers.
Should I File a Tylenol Lawsuit or Join an MDL?
If your child was diagnosed with autism or ADHD and you suspect the use of Tylenol during pregnancy to be the culprit, you may qualify to file a Tylenol lawsuit or join an MDL against Kenvue or other defendants. However, you will need to prove the link between the use of Tylenol and your child’s condition. This may require the assistance of a knowledgeable lawyer who can build a compelling case on your behalf and establish the link between prenatal acetaminophen usage and the child’s autism, ADHD, or other conditions.
Not sure where to find the right lawyer for your case? ConsumerShield can help connect you with lawyers specialized in Tylenol lawsuits so you can better understand your legal rights and options for compensation.
Has Your Child Been Harmed by Tylenol Exposure?
Manufacturers of dangerous drugs must be held accountable for the harm they cause. If you suspect your child was harmed by Tylenol during your pregnancy, you could recover compensation in the future.
A product liability attorney can evaluate your case and help you determine the next steps, and ConsumerShield can help you find the right lawyer for you. Fill out our contact form to get started for free!
Tylenol Lawsuit Knowledge Base
No topics match your search.
Frequently Asked Questions
The main claim in the Tylenol autism lawsuits alleges that in utero exposure to Tylenol may lead to higher rates of autism and other Tylenol-related neurologic disorders in children.
This lawsuit is significant because it allows a group of individuals who share similar claims to collectively pursue legal action against a common defendant, in this case, the manufacturer of Tylenol. Consolidating cases into an MDL can streamline legal proceedings, address common issues efficiently, and potentially lead to a collective resolution for affected individuals.
Families who believe they have been affected by the alleged side effects of Tylenol and are considering joining the lawsuit can contact legal representatives who specialize in handling Tylenol lawsuits. These attorneys can provide information, evaluate individual cases, and guide families through the process of potentially joining the legal action.
Settlement amounts generally depend on the severity of the autism spectrum disorder (ASD Level 1, 2, or 3) and the extent of acetaminophen use during pregnancy. Economic losses like medical bills and caretaking costs, as well as non-economic losses such as mental anguish and reduced quality of life, may also influence the compensation amount.
Resources
Explore related articles and sources cited on this page.
